Check out this week’s medical marketing news, people on the move and industry chatter.
Oh has worked at Marina Maher and most recently at Edelman.
Both drugmakers made financial leadership changes and released their respective latest earnings reports.
The move comes 18 months after the agency was acquired by PE firm WindRose Health Investors.
Former CEO and founder Phil Greenough moves to executive chairman as Festa O’Brien becomes the firm’s first female chief executive.
In this position at HH&Y, Hussain will be charged with leading the agency’s interactions with rare disease communities and optimizing its clients’ rare disease commercialization efforts.
Briantais will move to New York in June after spending more than four years leading marketing for Colgate in Asia-Pacific.
Schoen’s appointment is one of a series of healthcare promotions at the network.
MM+M Transform: The Patient, Provider and Payer Engagement Matrix provides the most in-depth look at the marketing and technology trends likely to influence the industry’s growth over the next year.
Get the most out of
Register for free and enjoy unlimited access to: